These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 33193275)

  • 1. An Evaluation of BfmR-Regulated Antimicrobial Resistance in the Extensively Drug Resistant (XDR)
    Marr CM; MacDonald U; Trivedi G; Chakravorty S; Russo TA
    Front Microbiol; 2020; 11():595798. PubMed ID: 33193275
    [No Abstract]   [Full Text] [Related]  

  • 2. The Response Regulator BfmR Is a Potential Drug Target for Acinetobacter baumannii.
    Russo TA; Manohar A; Beanan JM; Olson R; MacDonald U; Graham J; Umland TC
    mSphere; 2016; 1(3):. PubMed ID: 27303741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selectable Markers for Use in Genetic Manipulation of Extensively Drug-Resistant (XDR)
    Luna BM; Ulhaq A; Yan J; Pantapalangkoor P; Nielsen TB; Davies BW; Actis LA; Spellberg B
    mSphere; 2017; 2(2):. PubMed ID: 28497114
    [No Abstract]   [Full Text] [Related]  

  • 4. Determining the Development of Persisters in Extensively Drug-Resistant Acinetobacter baumannii upon Exposure to Polymyxin B-Based Antibiotic Combinations Using Flow Cytometry.
    Wong FH; Cai Y; Leck H; Lim TP; Teo JQ; Lee W; Koh TH; Tan TT; Tan KW; Kwa AL
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31818819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extensively drug-resistant Acinetobacter baumannii in a Thai hospital: a molecular epidemiologic analysis and identification of bactericidal Polymyxin B-based combinations.
    Teo J; Lim TP; Hsu LY; Tan TY; Sasikala S; Hon PY; Kwa AL; Apisarnthanarak A
    Antimicrob Resist Infect Control; 2015; 4(1):2. PubMed ID: 25648393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of sub-inhibitory concentrations of meropenem and tigecycline on the expression of genes regulating pili, efflux pumps and virulence factors involved in biofilm formation by
    Navidifar T; Amin M; Rashno M
    Infect Drug Resist; 2019; 12():1099-1111. PubMed ID: 31190904
    [No Abstract]   [Full Text] [Related]  

  • 7. The Structure of the Biofilm-controlling Response Regulator BfmR from Acinetobacter baumannii Reveals Details of Its DNA-binding Mechanism.
    Draughn GL; Milton ME; Feldmann EA; Bobay BG; Roth BM; Olson AL; Thompson RJ; Actis LA; Davies C; Cavanagh J
    J Mol Biol; 2018 Mar; 430(6):806-821. PubMed ID: 29438671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The combination effect of meropenem/sulbactam/polymyxin-B on the pharmacodynamic parameters for mutant selection windows against carbapenem-resistant
    Zhang J; Diao S; Liu Y; Wang H; Liu Y; Zhu S; Feng K; Tang X; Oo C; Zhu P; Lv Z; Yu M; Sy SKB; Zhu Y
    Front Microbiol; 2022; 13():1024702. PubMed ID: 36483204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of Acinetobacter baumannii response regulator BfmR in pellicle formation and competitiveness via contact-dependent inhibition system.
    Krasauskas R; Skerniškytė J; Armalytė J; Sužiedėlienė E
    BMC Microbiol; 2019 Nov; 19(1):241. PubMed ID: 31690263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamic Effects of Sulbactam/Meropenem/Polymyxin-B Combination Against Extremely Drug Resistant
    Menegucci TC; Fedrigo NH; Lodi FG; Albiero J; Nishiyama SAB; Mazucheli J; Carrara-Marroni FE; Voelkner NMF; Gong H; Sy SKB; Tognim MCB
    Microb Drug Resist; 2019 Nov; 25(9):1266-1274. PubMed ID: 31216222
    [No Abstract]   [Full Text] [Related]  

  • 11.
    Meng Q; Lin F; Ling B
    Front Pharmacol; 2022; 13():890955. PubMed ID: 35645826
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antimicrobial resistance of Gram-negative bacilli isolated from 13 teaching hospitals across China].
    Wang Q; Zhao CJ; Wang H; Yu YS; Zhu ZH; Chu YZ; Sun ZY; Hu ZD; Xu XL; Liao K; Xu YC; Zhang LY; Mei YN; Yang B; Ni YX
    Zhonghua Yi Xue Za Zhi; 2013 May; 93(18):1388-96. PubMed ID: 24025503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymyxin-resistant, carbapenem-resistant Acinetobacter baumannii is eradicated by a triple combination of agents that lack individual activity.
    Lenhard JR; Thamlikitkul V; Silveira FP; Garonzik SM; Tao X; Forrest A; Soo Shin B; Kaye KS; Bulitta JB; Nation RL; Li J; Tsuji BT
    J Antimicrob Chemother; 2017 May; 72(5):1415-1420. PubMed ID: 28333347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Identification of Resistance Determinants, Integrons and Genetic Relatedness of Extensively Drug Resistant Acinetobacter baumannii Isolated From Hospitals in Tehran, Iran.
    Najar Peerayeh S; Karmostaji A
    Jundishapur J Microbiol; 2015 Jul; 8(7):e27021. PubMed ID: 26421140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biofilm prevention concentrations (BPC) of minocycline compared to polymyxin B, meropenem, and amikacin against Acinetobacter baumannii.
    Beganovic M; Luther MK; Daffinee KE; LaPlante KL
    Diagn Microbiol Infect Dis; 2019 Jul; 94(3):223-226. PubMed ID: 30827805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Desiccation tolerance in Acinetobacter baumannii is mediated by the two-component response regulator BfmR.
    Farrow JM; Wells G; Pesci EC
    PLoS One; 2018; 13(10):e0205638. PubMed ID: 30308034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High throughput virtual screening and molecular dynamics simulation analysis of phytomolecules against BfmR of
    Lokhande KB; Pawar SV; Madkaiker S; Nawani N; Venkateswara SK; Ghosh P
    J Biomol Struct Dyn; 2023 Apr; 41(7):2698-2712. PubMed ID: 35156902
    [No Abstract]   [Full Text] [Related]  

  • 18. Polymyxin Resistance Among XDR ST1 Carbapenem-Resistant
    Carrasco LDM; Dabul ANG; Boralli CMDS; Righetto GM; Carvalho ISE; Dornelas JV; Martins da Mata CPS; de Araújo CA; Leite EMM; Lincopan N; Camargo ILBDC
    Front Microbiol; 2021; 12():622704. PubMed ID: 33897637
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of intravenous plus intrathecal/intracerebral ventricle injection of polymyxin B for post-neurosurgical intracranial infections due to MDR/XDR
    Pan S; Huang X; Wang Y; Li L; Zhao C; Yao Z; Cui W; Zhang G
    Antimicrob Resist Infect Control; 2018; 7():8. PubMed ID: 29387342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minocycline Alone and in Combination with Polymyxin B, Meropenem, and Sulbactam against Carbapenem-Susceptible and -Resistant Acinetobacter baumannii in an
    Beganovic M; Daffinee KE; Luther MK; LaPlante KL
    Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33318006
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.